Capricor Therapeutics CAPR Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Capricor Therapeutics's operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Capricor Therapeutics's operating lease liabilities (total)?
- Capricor Therapeutics (CAPR) reported operating lease liabilities (total) of $14.78M in Q1 2026.
- How has Capricor Therapeutics's operating lease liabilities (total) changed year-over-year?
- Capricor Therapeutics's operating lease liabilities (total) increased by 1083.3% year-over-year, from $1.25M to $14.78M.
- What is the long-term trend for Capricor Therapeutics's operating lease liabilities (total)?
- Over 4 years (2021 to 2025), Capricor Therapeutics's operating lease liabilities (total) has grown at a 50.0% compound annual growth rate (CAGR), from $2.87M to $14.52M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.